Extract from the Register of European Patents

EP About this file: EP1987141

EP1987141 - COMPOSITIONS SUITABLE FOR TREATING COLLAGEN-MEDIATED DISEASES [Right-click to bookmark this link]
Former [2008/45]COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
[2018/17]
StatusNo opposition filed within time limit
Status updated on  11.10.2019
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  03.12.2018
FormerGrant of patent is intended
Status updated on  03.05.2018
FormerExamination is in progress
Status updated on  08.12.2016
Most recent event   Tooltip28.05.2021Lapse of the patent in a contracting state
New state(s): CY
published on 30.06.2021  [2021/26]
Applicant(s)For all designated states
Endo Global Ventures
22 Victoria Street, Canon's Court
Hamilton HM12 / BM
For all designated states
BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook, NY 11563 / US
[2019/02]
Former [2013/18]For all designated states
Auxilium International Holdings, Inc.
1105 N. Market Street, Suite 1300
Wilmington, DE 19801 / US
For all designated states
BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook, NY 11563 / US
Former [2008/45]For all designated states
Auxilium International Holdings, Inc.
1105 N. Market Street, Suite 1300
Wilmington, DE 19801 / US
Inventor(s)01 / SABATINO, Gregory, L.
73 North Iroquois Lane
Chester Springs, PA 19425 / US
02 / DEL TITO, JR., Benjamin, J.
4071 Red Bud Circle
Doylestown, PA 18901 / US
03 / BASSETT, Phillip, J.
27 Buckmaster Avenue
Newcastle-under-lyme
Staffordshire ST5 3AL / GB
04 / THARIA, Hazel, A.
17 Chidlow Close, Hough
Nr Crewe, Cheshire CW2 5RE / GB
05 / HITCHCOCK, Antony, G.
14 Minster Court
Wistaston, Crewe CW2 8HL / GB
06 / YU, Bo
BioSpecifics Technologies Corporation
35 Wilbur Street, Lynbrook
New York 11563 / US
07 / WEGMAN, Thomas L.
BioSpecifics Technologies Corporation
35 Wilbur Street, Lynbrook
New York 11563 / US
 [2013/06]
Former [2008/45]01 / SABATINO, Gregory, L.
73 North Iroquois Lane
Chester Springs, PA 19425 / US
02 / DEL TITO, JR., Benjamin, J.
4071 Red Bud Circle
Doylestown, PA 18901 / US
03 / BASSETT, Phillip, J.
27 Buckmaster Avenue Newcastle-under-lyme
Staffordshire ST5 3AL / GB
04 / THARIA, Hazel, A.
17 Chidlow Close, Hough
Nr Crewe, Cheshire CW2 5RE / GB
05 / HITCHCOCK, Antony, G.
14 Minster Court
Wistaston, Crewe CW2 8HL / GB
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2018/49]
Former [2008/45]Chapman, Paul William
Kilburn & Strode 20 Red Lion Street London
WC1R 4PJ / GB
Application number, filing date07762860.030.01.2007
[2008/45]
WO2007US02654
Priority number, dateUS20060763470P30.01.2006         Original published format: US 763470 P
US20060784135P20.03.2006         Original published format: US 784135 P
US2007069930229.01.2007         Original published format: US 699302
[2008/45]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007089851
Date:09.08.2007
Language:EN
[2007/32]
Type: A2 Application without search report 
No.:EP1987141
Date:05.11.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 09.08.2007 takes the place of the publication of the European patent application.
[2008/45]
Type: B1 Patent specification 
No.:EP1987141
Date:05.12.2018
Language:EN
[2018/49]
Type: B8 Corrected title page of specification 
No.:EP1987141
Date:06.03.2019
[2019/10]
Search report(s)International search report - published on:US03.01.2008
(Supplementary) European search report - dispatched on:EP21.10.2009
ClassificationIPC:C12N9/52, C12N9/20
[2008/45]
CPC:
A61K38/4886 (EP,CN,IL,US); A61K38/48 (IL,KR); A61K9/0019 (IL,US);
A61K9/08 (IL,KR); A61K9/19 (IL,US); A61P17/00 (EP,IL);
A61P17/02 (EP,IL); A61P17/10 (EP,IL); A61P19/02 (EP,IL);
A61P19/04 (EP,IL); A61P35/00 (EP,IL); A61P43/00 (EP,IL);
C12N9/20 (IL,KR); C12N9/52 (EP,CN,IL,KR,US); C12Y304/24007 (EP,IL,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/49]
Former [2008/45]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL28.08.2008
BA28.08.2008
HR28.08.2008
MK28.08.2008
RS28.08.2008
TitleGerman:ZUSAMMENSETZUNGEN ZUR BEHANDLUNG COLLAGEN-BEDINGTER KRANKHEITEN[2018/17]
English:COMPOSITIONS SUITABLE FOR TREATING COLLAGEN-MEDIATED DISEASES[2018/17]
French:COMPOSITIONS DE TRAITEMENT DES MALADIES MÉDIÉES PAR LE COLLAGÈNE[2018/17]
Former [2008/45]ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG COLLAGEN-BEDINGTER KRANKHEITEN
Former [2008/45]COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
Former [2008/45]COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DES MALADIES MÉDIÉES PAR LE COLLAGÈNE
Entry into regional phase28.08.2008National basic fee paid 
28.08.2008Search fee paid 
28.08.2008Designation fee(s) paid 
28.08.2008Examination fee paid 
Examination procedure27.08.2008Amendment by applicant (claims and/or description)
28.08.2008Examination requested  [2008/45]
02.02.2010Despatch of a communication from the examining division (Time limit: M06)
10.08.2010Reply to a communication from the examining division
28.04.2011Despatch of a communication from the examining division (Time limit: M06)
04.11.2011Reply to a communication from the examining division
11.06.2012Despatch of a communication from the examining division (Time limit: M06)
20.12.2012Reply to a communication from the examining division
09.09.2014Despatch of a communication from the examining division (Time limit: M06)
18.03.2015Reply to a communication from the examining division
04.05.2016Despatch of a communication from the examining division (Time limit: M06)
09.12.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
15.02.2017Reply to a communication from the examining division
21.03.2018Cancellation of oral proceeding that was planned for 17.04.2018
17.04.2018Date of oral proceedings (cancelled)
04.05.2018Communication of intention to grant the patent
14.09.2018Fee for grant paid
14.09.2018Fee for publishing/printing paid
14.09.2018Receipt of the translation of the claim(s)
Divisional application(s)EP12155228.5  / EP2474319
EP12155230.1  / EP2474320
EP12155233.5  / EP2474321
EP18209918.4  / EP3508571
EP24194815.7
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.02.2010
Opposition(s)06.09.2019No opposition filed within time limit [2019/46]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
15.02.2017Request for further processing filed
15.02.2017Full payment received (date of receipt of payment)
Request granted
01.03.2017Decision despatched
Fees paidRenewal fee
30.01.2009Renewal fee patent year 03
25.01.2010Renewal fee patent year 04
25.01.2011Renewal fee patent year 05
25.01.2012Renewal fee patent year 06
25.01.2013Renewal fee patent year 07
27.01.2014Renewal fee patent year 08
27.01.2015Renewal fee patent year 09
08.01.2016Renewal fee patent year 10
09.01.2017Renewal fee patent year 11
08.01.2018Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.12.2018
EE05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
PL05.12.2018
RO05.12.2018
SI05.12.2018
SK05.12.2018
BG05.03.2019
IS05.04.2019
[2021/26]
Former [2019/50]EE05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
PL05.12.2018
RO05.12.2018
SI05.12.2018
SK05.12.2018
BG05.03.2019
IS05.04.2019
Former [2019/45]EE05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
PL05.12.2018
RO05.12.2018
SK05.12.2018
BG05.03.2019
IS05.04.2019
Former [2019/39]EE05.12.2018
LT05.12.2018
LV05.12.2018
PL05.12.2018
RO05.12.2018
SK05.12.2018
BG05.03.2019
IS05.04.2019
Former [2019/37]EE05.12.2018
LT05.12.2018
LV05.12.2018
PL05.12.2018
RO05.12.2018
BG05.03.2019
Former [2019/35]LT05.12.2018
LV05.12.2018
PL05.12.2018
BG05.03.2019
Former [2019/23]LT05.12.2018
LV05.12.2018
BG05.03.2019
Former [2019/22]LT05.12.2018
BG05.03.2019
Former [2019/20]LT05.12.2018
Documents cited:Search[X] WO9824889  (BOEHRINGER MANNHEIM CORP et al.) [X] 1-39 * claims 5,6 *
 [X] WO9600283  (BOEHRINGER MANNHEIM CORP et al.) [X] 1-39 * page 7, line 5 *
International search[Y] US5952215  (DWULET FRANCIS E et al.)
 [Y] US5989888  (DWULET FRANCIS E et al.)
 [Y] US2004137596  (KURFUERST MANFRED et al.)
 [Y] US6475764  (BURTSCHER HELMUT et al.)
by applicantWO9824889
 US2004137596
 US6086872
 US5589171
 US6022539
   "Clostridium histolyticum", 1956, DR. I. MANDL'S LABORATORY IN COLUMBIA UNIVERSITY, article "Clostridium histolyticum"
   EDDIE L. ANGLETON; H. E. VAN WART, BIOCHEMISTRY, vol. 27, 1988, pages 7406 - 7412
   STEINBRINK, D; BOND, M; VAN WART, H, JBC, vol. 260, 1985, pages 2771 - 2776
   STEINBRINK, D; BOND, M; VAN WART, H, JBC, vol. 260, 1985, pages 277 - 2776
   MANDL, I., BIOCHEMISTRY, vol. 3, 1964, pages 1737 - 1741
   VOS-SCHEPERKEUTER, GH, CELL TRANSPLANTATION, vol. 6, 1997, pages 403 - 412
   BOND, M.D., BIOCHEMISTRY, vol. 23, 1984, pages 3085 - 3091
   HESSE, F, TRANSPLANTATION PROCEEDINGS, vol. 27, 1995, pages 3287 - 3289
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.